Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Launches ZzzQuil To Enter OTC Sleep Aid Category

This article was originally published in The Tan Sheet

Executive Summary

While other national brand names compete in the OTC sleep aid tablet category, P&G’s NyQuil line extension is by far the biggest name among current players in the liquid product category, which has annual growth of nearly 80%.

You may also be interested in...



With Zzzquil Efficacy Tests, P&G Highlights OTC Sleep Aid Indication

Sleep researchers recognize many consumers look at Rx sleep disturbance treatments and OTC sleep aids as the same type of products. Still, "people are looking for options that are effective and non-habit-forming and help them get to sleep quickly," says P&G researcher Andrew Carr.

With Zzzquil Efficacy Tests, P&G Highlights OTC Sleep Aid Indication

Sleep researchers recognize many consumers look at Rx sleep disturbance treatments and OTC sleep aids as the same type of products. Still, "people are looking for options that are effective and non-habit-forming and help them get to sleep quickly," says P&G researcher Andrew Carr.

P&G’s ZzzQuil Emerges As Sleep Aid Giant In Fragmented Category

The combination of appealing marketing, single-ingredient formulation and Vicks brand equity helped Procter & Gamble’s ZzzQuil rise to the top of the sleep aid segment. The firm recruited actress Katherine Heigl as ZzzQuil ambassador to help amplify the brand’s marketing strategy in its second year.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105812

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel